Using 3D ultrasound to improve brain tumor surgery
Official title: Evaluation of 3D Ultrasound in Brain Tumor Surgery
Run by University of Ulm · NCT05956977 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether using 3D ultrasound during brain tumor surgery can help doctors remove more of the tumor and improve patient outcomes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | University of Ulm Academic / other |
| Locations | 2 sites (Tübingen, Baden Würtemberg and 1 other locations) |
| Trial ID | NCT05956977 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with suspected intra-axial lesions who are eligible for potential gross total resection.
✕Probably not a fit
Patients who are unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of 3D ultrasound technology in enhancing the surgical resection of brain tumors. It aims to determine how the use of this imaging technique impacts the extent of tumor removal, as well as secondary outcomes such as neurological results, accuracy, and image quality. Participants will undergo surgery with the assistance of 3D ultrasound, while a control group will consist of patients from a retrospective matched pair cohort. The study focuses on patients with suspected intra-axial lesions, including metastasis or glioma.
Why it matters
Potential benefit: If successful, this approach could lead to more complete tumor resections and improved neurological outcomes for patients undergoing brain surgery.
How similar studies have gone: While the use of ultrasound in surgery is established, the specific application of 3D ultrasound in brain tumor surgery is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age above 18 suspected intra-axial lesion (metastasis or Glioma) potential gross total resection of lesion Exclusion Criteria: * no ability for informed consent
Where it's running
-
University of Tübingen
Tübingen, Baden Würtemberg, Germany Recruiting -
University of Ulm
Ulm, Germany Recruiting
Study contacts
- Study coordinator: Jan Coburger, apl. Prof. Dr. med.
- Email: jan.coburger@uni-ulm.de
- Phone: 0822196
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combining chemoimmunotherapy with radiation for extensive stage small-cell lung cancer
This study is testing if combining a new type of cancer treatment with radiation can help people with advanced small-cell lung cancer live longer and feel better.
-
Glucose levels during a 6 km loaded march
We will test how blood sugar changes during a 6 km march carrying 15 kg of equipment in healthy soldiers using continuous glucose monitors.
-
Parental metabolism's imprint on the fetal epigenome in gestational diabetes
We will see if parents' metabolism during pregnancy is linked to epigenetic changes in the fetus in pregnancies with and without gestational diabetes.
-
How changing thyroid hormone levels affects blood sugar, lipids, and energy use
This trial will test whether raising or lowering thyroid hormones in people with newly diagnosed Graves' disease or thyroid cancer changes blood sugar, insulin, and lipid metabolism using oral glucose tolerance tests.
-
Once-weekly semaglutide for weight loss in adolescents with monogenic obesity
This study tests whether once-weekly semaglutide 2.4 mg together with a reduced-calorie diet and increased activity helps adolescents with monogenic obesity lose weight, reduce hunger, and improve quality of life over 68 weeks.
-
Global registry for genetic obesity
This registry collects health and genetic information from people with genetically confirmed or early-onset severe obesity to see if different genes relate to symptoms, complications, and treatment responses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.